GM Advisory Group Inc. Boosts Holdings in UnitedHealth Group Inc (NYSE:UNH)

GM Advisory Group Inc. boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,712 shares of the healthcare conglomerate’s stock after acquiring an additional 45 shares during the period. GM Advisory Group Inc.’s holdings in UnitedHealth Group were worth $1,685,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the stock. Successful Portfolios LLC increased its position in shares of UnitedHealth Group by 2.2% in the second quarter. Successful Portfolios LLC now owns 1,558 shares of the healthcare conglomerate’s stock valued at $460,000 after buying an additional 34 shares in the last quarter. SRS Capital Advisors Inc. increased its position in shares of UnitedHealth Group by 3.6% in the second quarter. SRS Capital Advisors Inc. now owns 981 shares of the healthcare conglomerate’s stock valued at $289,000 after buying an additional 34 shares in the last quarter. Investment Counsel Inc. increased its position in shares of UnitedHealth Group by 1.4% in the second quarter. Investment Counsel Inc. now owns 2,575 shares of the healthcare conglomerate’s stock valued at $759,000 after buying an additional 35 shares in the last quarter. Bfsg LLC increased its position in shares of UnitedHealth Group by 1.7% in the second quarter. Bfsg LLC now owns 2,083 shares of the healthcare conglomerate’s stock valued at $614,000 after buying an additional 35 shares in the last quarter. Finally, Parkside Investments LLC increased its position in shares of UnitedHealth Group by 0.3% in the second quarter. Parkside Investments LLC now owns 13,409 shares of the healthcare conglomerate’s stock valued at $3,955,000 after buying an additional 35 shares in the last quarter. 86.39% of the stock is owned by institutional investors.

A number of brokerages have recently weighed in on UNH. Morgan Stanley restated a “buy” rating and issued a $371.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. ValuEngine downgraded shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, July 2nd. Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $325.00 to $335.00 and gave the company an “outperform” rating in a research note on Thursday, July 16th. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Friday, June 5th. They set a “buy” rating and a $384.00 price objective on the stock. Finally, Raymond James upped their price objective on shares of UnitedHealth Group from $325.00 to $350.00 and gave the company a “strong-buy” rating in a research note on Thursday, July 16th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $339.52.

Shares of UnitedHealth Group stock traded down $4.01 during trading hours on Thursday, hitting $316.23. The company’s stock had a trading volume of 3,868,191 shares, compared to its average volume of 4,520,187. UnitedHealth Group Inc has a 1-year low of $187.72 and a 1-year high of $324.57. The business has a fifty day moving average of $310.50 and a 200 day moving average of $287.57. The company has a market capitalization of $297.29 billion, a PE ratio of 17.79, a P/E/G ratio of 1.49 and a beta of 0.68. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, July 15th. The healthcare conglomerate reported $7.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.28 by $1.84. The business had revenue of $62.10 billion during the quarter, compared to analyst estimates of $63.54 billion. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The business’s revenue was up 2.5% on a year-over-year basis. During the same period last year, the business earned $3.60 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Inc will post 16.58 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Friday, September 11th. UnitedHealth Group’s payout ratio is 33.09%.

In other UnitedHealth Group news, EVP Marianne D. Short sold 12,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the completion of the transaction, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stephen J. Hemsley sold 59,012 shares of the firm’s stock in a transaction on Thursday, July 16th. The stock was sold at an average price of $307.04, for a total transaction of $18,119,044.48. Following the transaction, the director now directly owns 909,059 shares of the company’s stock, valued at $279,117,475.36. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 128,522 shares of company stock valued at $39,886,448. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is Liquidity?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit